Controlled studies of the efficacy and safety of combined probucol-colestipol therapy
- 27 June 1986
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 57 (16), H36-H41
- https://doi.org/10.1016/0002-9149(86)90435-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Low-dose colestipol plus probucol for hypercholesterolemiaThe American Journal of Cardiology, 1984
- Probucol with Colestipol in the Treatment of HypercholesterolemiaAnnals of Internal Medicine, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- Electrocardiographic effects of probucol. A controlled prospective clinical trialEuropean Journal of Clinical Pharmacology, 1984
- Reduction of Serum Cholesterol in Heterozygous Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1983
- Effect of probucol on cholesterol synthesis, plasma lipoproteins and the activities of lipoprotein and hepatic lipase in the ratAtherosclerosis, 1981
- Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug RegimenNew England Journal of Medicine, 1981
- Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemiaMetabolism, 1980
- Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein CatabolismNew England Journal of Medicine, 1980
- A two-year crossover therapeutic trial with halofenate and clofibrateThe American Journal of the Medical Sciences, 1976